Breaking News on Contract Research, Manufacturing & Clinical Trials |
Related topics: Contract Manufacturing, Analytical testing, QC, Bulk ingredients, Contract sales & marketing, Data management, Drug delivery, formulation, Fill & finish, packaging, Phase I-II, Phase III-IV, Preclinical, Product & Supplier News - Contract Manufacturing, Regulatory affairs, Supply chain, logistics, Validation services
After months of deliberations, a court in Iowa has opted to fine contract manufacturing company Cambrex $6,000 for safety violations after an explosion at its facility in Charles City.
Six employees were injured in the blast last October, which occurred in the plant's drying department. One worker was seriously burned and five others were treated for smoke inhalation.
In February, the Iowa Occupational Safety and Health Bureau determined there was insufficient training of employees and inadequate notification and documentation of possible hazards at the plant.
Copyright - Unless otherwise stated all contents of this web site are © 2000/2009 - Decision News Media SAS - All Rights Reserved - For permission to reproduce any contents of this web site, please email our Syndication department: Administration & Finance - Full details for the use of materials on this site can be found in the Terms & Conditions
Food & Beverage: Food & Beverage Development - Europe | Food & Beverage Development - North America | Food Marketing and Retailing | Food Processing & Packaging | Food Safety & Quality Control | Food and Beverage in Asia Pacific | Industrial Baking & Snacks | Beverage Technology & Markets | Confectionery & Biscuit Processing | Dairy Processing & Markets | Prepared Food and Meat Processing Nutrition: Supplements & Nutrition - Europe | Supplements & Nutrition - North America Pharmaceutical: Pharmaceutical Technology | Drug Discovery | Laboratory Equipment | Contract Research, Manufacturing & Clinical Trials Cosmetics: Cosmetics Formulation & Packaging - North America | Cosmetics Formulation & Packaging - Europe
© 2000/2009 - Decision News Media SAS - All right reserved.
